Sanofi (SNY) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Drug Manufacturers - General Branche. Der Hauptsitz des Unternehmens ist in Paris, France. Der aktuelle CEO ist Olivier Charmeil.
SNY hat IPO-Datum 2002-07-01, 82,878 Vollzeitbeschäftigte, gelistet an der NASDAQ Global Select, eine Marktkapitalisierung von $116.02B.
Sanofi is a Paris-based pharmaceutical and healthcare company that researches, develops, manufactures, and markets a comprehensive range of therapeutic solutions globally. The company operates through three primary segments: Pharmaceuticals, Vaccines, and Consumer Healthcare, offering specialty care products for conditions including multiple sclerosis, immunology, rare diseases, oncology, and diabetes, alongside a broad portfolio of pediatric and adult vaccines covering poliomyelitis, influenza, meningitis, and other endemic diseases. Sanofi also provides consumer health products spanning allergy relief, pain management, digestive wellness, and dermatological care. The company maintains strategic collaborations with leading institutions, including GlaxoSmithKline for COVID-19 vaccine development and Stanford University School of Medicine for immunology research, positioning itself as a diversified leader in both prescription pharmaceuticals and preventive healthcare.
